Skip to content
healthcare.dev

Fungus Nosode

NDC 43406-0120, Achorion Scho, Alternaria Alt, Aspergillus Fum, Aspergillus Niger, Boletus Sat, Botrytis Cin, Candida Parap, Cladosporium Met, Fusarium Oxy, Helminthosporium Sat, Microsporon Fur, Mucor Muecedo, Pullularia Pull, Rhizopus Nig, Saccharomyces Cer, Trichophyton Spp, Ustilago Maydis, liquid, from Natural Creations, Inc.

Product NDC
43406-0120
Status
Listed
Labeler
Natural Creations, Inc
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43406-0120 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRICHOPHYTON SCHOENLEINII200 [hp_X]/mL
  • ALTERNARIA ALTERNATA200 [hp_X]/mL
  • ASPERGILLUS FUMIGATUS200 [hp_X]/mL
  • ASPERGILLUS NIGER VAR. NIGER200 [hp_X]/mL
  • BOLETUS SATANAS FRUITING BODY200 [hp_X]/mL
  • BOTRYTIS CINEREA200 [hp_X]/mL
  • CANDIDA PARAPSILOSIS200 [hp_X]/mL
  • HORTAEA WERNECKII200 [hp_X]/mL
  • FUSARIUM OXYSPORUM200 [hp_X]/mL
  • COCHLIOBOLUS SATIVUS200 [hp_X]/mL
  • RHIZOPUS STOLONIFER200 [hp_X]/mL
  • AUREOBASIDIUM PULLULANS VAR. PULLUTANS200 [hp_X]/mL
  • SACCHAROMYCES CEREVISIAE RNA200 [hp_X]/mL
  • EPIDERMOPHYTON FLOCCOSUM200 [hp_X]/mL
  • USTILAGO MAYDIS200 [hp_X]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]

Package NDCNDC-11Package
43406-0120-14340601200130 mL in 1 BOTTLE, DROPPER (43406-0120-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 43406-0120 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43406-0120 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43406-0120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.